Genocea Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Genocea Biosciences

05/05/2022 22:31

* Genocea Biosciences Inc  GNCA.OQ  reported a quarterly
adjusted
loss of 22 cents​​ per share for the quarter ended in March. The
mean expectation of five analysts for the quarter was for a loss
of 18 cents per share.
    * Revenue was $270.00 thousand​;  analysts expected $425.00
thousand. 
    * The mean earnings estimate of analysts had fallen by
about 7.1%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Genocea Biosciences Inc shares had fallen by 79.3% this
quarter and lost 77.7% so far this year.
    * Wall Street's median 12-month price target for Genocea
Biosciences Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 5 at 09:31 p.m.  ​All
figures in US dollars unless otherwise stated